Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-30

FDA Approved: DEFITELIO — Original Application (Jazz Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Defibrotide (Defitelio) as the original application for the treatment of hepatic veno-occlusive disease in adults and children after hematopoie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Defitelio (defibrotide)

Snippet

ORIG AP for DEFITELIO (DEFIBROTIDE SODIUM)